These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16697759)

  • 1. MLN-02 in IBD: is "super-selective" really super?
    Cohen RD
    Gastroenterology; 2006 May; 130(6):1923-4. PubMed ID: 16697759
    [No Abstract]   [Full Text] [Related]  

  • 2. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
    Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S
    Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Duration of remission and long-term prognosis according to the extent of disease in patients with ulcerative colitis on continuous mesalamine treatment.
    Bresci G; Parisi G; Capria A
    Colorectal Dis; 2008 Oct; 10(8):814-7. PubMed ID: 18834420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 5-aminosalicylic acid formulations in ulcerative colitis: old dog, new tricks.
    Wilson J
    Gastroenterol Nurs; 2008; 31(4):286-92. PubMed ID: 18708833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous cyclosporine in severe ulcerative colitis: how low can you go?
    Regueiro M
    Inflamm Bowel Dis; 2004 Mar; 10(2):170. PubMed ID: 15168819
    [No Abstract]   [Full Text] [Related]  

  • 6. Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study.
    Scherl EJ; Pruitt R; Gordon GL; Lamet M; Shaw A; Huang S; Mareya S; Forbes WP
    Am J Gastroenterol; 2009 Jun; 104(6):1452-9. PubMed ID: 19491859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of inflammatory bowel disease with methotrexate in clinical practice.
    Magalhães RK; Lago P; Pedroto I
    J Crohns Colitis; 2013 Dec; 7(11):e606. PubMed ID: 23871412
    [No Abstract]   [Full Text] [Related]  

  • 8. Antibiotics and probiotics in inflammatory bowel disease: why, when, and how.
    Prantera C; Scribano ML
    Curr Opin Gastroenterol; 2009 Jul; 25(4):329-33. PubMed ID: 19444096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Manitoba IBD Index: evidence for a new and simple indicator of IBD activity.
    Clara I; Lix LM; Walker JR; Graff LA; Miller N; Rogala L; Rawsthorne P; Bernstein CN
    Am J Gastroenterol; 2009 Jul; 104(7):1754-63. PubMed ID: 19455122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tramadol pharmacokinetics and its possible interactions with cyclooxygenase 2-selective nonsteroidal anti-inflammatory drugs.
    Punwani NG
    Clin Pharmacol Ther; 2004 Apr; 75(4):363-5. PubMed ID: 15060515
    [No Abstract]   [Full Text] [Related]  

  • 11. Colectomy rate in steroid-refractory colitis initially responsive to cyclosporin: a long-term retrospective cohort study.
    Actis GC; Fadda M; David E; Sapino A
    BMC Gastroenterol; 2007 Mar; 7():13. PubMed ID: 17389040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory Bowel Disease and Clostridium difficile-associated diarrhea: a growing problem.
    Tremaine WJ
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):310-1. PubMed ID: 17368229
    [No Abstract]   [Full Text] [Related]  

  • 13. Budesonide is effective in treating lymphocytic colitis: a randomized double-blind placebo-controlled study.
    Miehlke S; Madisch A; Karimi D; Wonschik S; Kuhlisch E; Beckmann R; Morgner A; Mueller R; Greinwald R; Seitz G; Baretton G; Stolte M
    Gastroenterology; 2009 Jun; 136(7):2092-100. PubMed ID: 19303012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laboratory evaluation of inflammatory bowel disease.
    Wong A; Bass D
    Curr Opin Pediatr; 2008 Oct; 20(5):566-70. PubMed ID: 18781120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Corticosteroid therapy for pericarditis: a double-edged sword.
    Imazio M; Brucato A; Trinchero R; Shabetai R; Spodick D; Adler Y
    Nat Clin Pract Cardiovasc Med; 2008 Mar; 5(3):118-9. PubMed ID: 18212773
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of ascorbic acid supplementation on plasma isoprostanes in haemodialysis patients.
    Chan D; Irish A; Croft KD; Dogra G
    Nephrol Dial Transplant; 2006 Jan; 21(1):234-5. PubMed ID: 16204285
    [No Abstract]   [Full Text] [Related]  

  • 17. [Activity indices--objective criteria of the estimation of severity level of ulcerous colitis].
    Bakulin IG; Stanke DA; Belousova EA; Golovenko OV; Mikhailova TL
    Eksp Klin Gastroenterol; 2008; (6):14-6. PubMed ID: 19334421
    [No Abstract]   [Full Text] [Related]  

  • 18. Pemphigus vulgaris and ulcerative colitis.
    Kacar S; Sezgin O; Sahin T
    Am J Gastroenterol; 2002 Feb; 97(2):507-8. PubMed ID: 11866312
    [No Abstract]   [Full Text] [Related]  

  • 19. Indeterminate colitis: a distinctive clinical pattern of inflammatory bowel disease in children.
    Romano C; Famiani A; Gallizzi R; Comito D; Ferrau' V; Rossi P
    Pediatrics; 2008 Dec; 122(6):e1278-81. PubMed ID: 19047226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of once- or twice-daily MMX mesalamine (SPD476) for the induction of remission of mild to moderately active ulcerative colitis.
    Lichtenstein GR; Kamm MA; Boddu P; Gubergrits N; Lyne A; Butler T; Lees K; Joseph RE; Sandborn WJ
    Clin Gastroenterol Hepatol; 2007 Jan; 5(1):95-102. PubMed ID: 17234558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.